| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| MousePheno | decreased grip strength | GDF5 COL6A3 RABGAP1 BTBD9 NSUN2 WDR47 TTC7A ARID1B TENM4 NRXN1 SACS PTPRR AGL SPOP MPHOSPH10 DYNC1H1 | 1.87e-05 | 575 | 115 | 16 | MP:0010053 |
| MousePheno | abnormal physical strength | GDF5 COL6A3 SYNE1 DGKB MECOM RABGAP1 BTBD9 NSUN2 WDR47 TTC7A COL24A1 ARID1B TENM4 DST NRXN1 SACS PTPRR AGL SPOP MPHOSPH10 DYNC1H1 PKN3 | 2.80e-05 | 1027 | 115 | 22 | MP:0004262 |
| Domain | Spectrin | 2.68e-05 | 23 | 144 | 4 | PF00435 | |
| Domain | ACTININ_2 | 2.68e-05 | 23 | 144 | 4 | PS00020 | |
| Domain | ACTININ_1 | 2.68e-05 | 23 | 144 | 4 | PS00019 | |
| Domain | Actinin_actin-bd_CS | 2.68e-05 | 23 | 144 | 4 | IPR001589 | |
| Domain | PACT_coil_coil | 5.90e-05 | 2 | 144 | 2 | PF10495 | |
| Domain | PACT_domain | 5.90e-05 | 2 | 144 | 2 | IPR019528 | |
| Domain | Spectrin_repeat | 6.93e-05 | 29 | 144 | 4 | IPR002017 | |
| Domain | SPEC | 1.03e-04 | 32 | 144 | 4 | SM00150 | |
| Domain | Spectrin/alpha-actinin | 1.03e-04 | 32 | 144 | 4 | IPR018159 | |
| Domain | AAA | 1.28e-04 | 144 | 144 | 7 | SM00382 | |
| Domain | AAA+_ATPase | 1.28e-04 | 144 | 144 | 7 | IPR003593 | |
| Domain | RasGEFN | 4.65e-04 | 20 | 144 | 3 | SM00229 | |
| Domain | RasGEF_N | 5.39e-04 | 21 | 144 | 3 | PF00618 | |
| Domain | Ras-like_Gua-exchang_fac_N | 6.21e-04 | 22 | 144 | 3 | IPR000651 | |
| Domain | RASGEF_NTER | 6.21e-04 | 22 | 144 | 3 | PS50212 | |
| Domain | - | 8.68e-04 | 6 | 144 | 2 | 3.90.1290.10 | |
| Domain | GAR | 8.68e-04 | 6 | 144 | 2 | PS51460 | |
| Domain | GAS2 | 8.68e-04 | 6 | 144 | 2 | PF02187 | |
| Domain | - | 8.68e-04 | 6 | 144 | 2 | 3.30.920.20 | |
| Domain | GAS_dom | 8.68e-04 | 6 | 144 | 2 | IPR003108 | |
| Domain | GAS2 | 8.68e-04 | 6 | 144 | 2 | SM00243 | |
| Domain | Kinase-like_dom | ACVR1B ACVR1C BMX DST PI4KB MACF1 PAN3 DNM1 MAP3K21 RIOK2 PKN3 SOS1 | 1.02e-03 | 542 | 144 | 12 | IPR011009 |
| Domain | GS_dom | 1.21e-03 | 7 | 144 | 2 | IPR003605 | |
| Domain | GS | 1.21e-03 | 7 | 144 | 2 | PS51256 | |
| Domain | Plectin | 1.21e-03 | 7 | 144 | 2 | PF00681 | |
| Domain | TGF_beta_GS | 1.21e-03 | 7 | 144 | 2 | PF08515 | |
| Domain | GS | 1.21e-03 | 7 | 144 | 2 | SM00467 | |
| Domain | Plectin_repeat | 1.21e-03 | 7 | 144 | 2 | IPR001101 | |
| Domain | PLEC | 1.21e-03 | 7 | 144 | 2 | SM00250 | |
| Pathway | REACTOME_SIGNALING_BY_HEDGEHOG | 4.27e-06 | 150 | 117 | 9 | M27440 | |
| Pathway | REACTOME_SIGNALING_BY_HEDGEHOG | 1.82e-05 | 137 | 117 | 8 | MM15182 | |
| Pathway | REACTOME_HEDGEHOG_OFF_STATE | 4.23e-05 | 113 | 117 | 7 | M27471 | |
| Pathway | REACTOME_HEDGEHOG_ON_STATE | 5.62e-05 | 81 | 117 | 6 | MM15225 | |
| Pathway | REACTOME_HEDGEHOG_ON_STATE | 7.87e-05 | 86 | 117 | 6 | M27497 | |
| Pathway | REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION | 8.47e-05 | 126 | 117 | 7 | M705 | |
| Pathway | REACTOME_CELL_CYCLE_CHECKPOINTS | PSMB1 PSMC5 PSME4 MDC1 HERC2 RPA2 DYNC1H1 DYNC1I2 RAD17 KIF2C | 8.54e-05 | 271 | 117 | 10 | MM15388 |
| Pathway | REACTOME_CELL_CYCLE_CHECKPOINTS | PSMB1 PSMC5 PSME4 MDC1 HERC2 RPA2 DYNC1H1 DYNC1I2 RAD17 KIF2C | 1.53e-04 | 291 | 117 | 10 | M16647 |
| Pathway | REACTOME_G2_M_CHECKPOINTS | 1.87e-04 | 143 | 117 | 7 | MM15383 | |
| Pathway | REACTOME_HEDGEHOG_OFF_STATE | 2.37e-04 | 105 | 117 | 6 | MM15206 | |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | DOCK11 ACTN1 CCDC88A DST WDR6 CLTC FAM169A TJP2 RACGAP1 ARHGAP28 PKN3 SOS1 | 2.85e-04 | 439 | 117 | 12 | MM15595 |
| Pathway | REACTOME_SIGNALING_BY_RHO_GTPASES_MIRO_GTPASES_AND_RHOBTB3 | DOCK11 ACTN1 CCDC88A DST WDR6 CLTC FAM169A TJP2 RACGAP1 ARHGAP28 DYNC1H1 PKN3 DYNC1I2 KIF2C SOS1 | 3.03e-04 | 649 | 117 | 15 | MM15690 |
| Pathway | REACTOME_RHO_GTPASE_CYCLE | DOCK11 ACTN1 CCDC88A DST WDR6 CLTC FAM169A TJP2 RACGAP1 ARHGAP28 PKN3 SOS1 | 3.57e-04 | 450 | 117 | 12 | M27078 |
| Pathway | REACTOME_MHC_CLASS_II_ANTIGEN_PRESENTATION | 4.06e-04 | 116 | 117 | 6 | MM14855 | |
| Pathway | WP_VASOPRESSINREGULATED_WATER_REABSORPTION | 4.74e-04 | 44 | 117 | 4 | M42554 | |
| Pathway | REACTOME_AGGREPHAGY | 4.74e-04 | 44 | 117 | 4 | M29830 | |
| Pathway | KEGG_VASOPRESSIN_REGULATED_WATER_REABSORPTION | 4.74e-04 | 44 | 117 | 4 | M9011 | |
| Pathway | REACTOME_G2_M_CHECKPOINTS | 4.80e-04 | 167 | 117 | 7 | M19381 | |
| Pubmed | KCTD9 ANK2 DOCK11 SYNE1 APC2 BTBD9 WDR47 LRIG2 FRY CCDC88A DST NF1 AKAP9 NRXN1 CLU PTPRN2 CLTC RACGAP1 PPP1R3F MACF1 HERC2 RAPGEF2 DNM1 DYNC1H1 PCNT KIF2C | 8.20e-14 | 963 | 150 | 26 | 28671696 | |
| Pubmed | Proteomic profiling of VCP substrates links VCP to K6-linked ubiquitylation and c-Myc function. | EIF4A3 TAF1B PSMB1 PSMC5 ACTN1 MCCC1 MTHFS PAPSS2 NSUN2 BIRC6 WDR47 LIG3 DST NF1 PSME4 WDR6 MDC1 CLTC RACGAP1 MACF1 AATF ACAA2 EXOC1 HERC2 RIOK2 DYNC1H1 DYNC1I2 ATP5F1B KIF2C | 8.24e-13 | 1353 | 150 | 29 | 29467282 |
| Pubmed | ANK2 SYNE1 RABGAP1 CCDC88A DST AKAP9 CLU MACF1 EXOC1 DYNC1H1 SOS1 | 6.35e-11 | 151 | 150 | 11 | 17043677 | |
| Pubmed | KDM5B ANK2 EIF4A3 SYNE1 APC2 ACTN1 EXTL3 NSUN2 WDR47 FRY DST IFT88 SACS CLU CLTC MACF1 EXOC1 EIF3C HERC2 RAPGEF2 DNM1 DYNC1H1 ATP5F1B PCNT SOS1 | 2.89e-10 | 1285 | 150 | 25 | 35914814 | |
| Pubmed | SYNE1 KDM3B BIRC6 ADCY6 TTC7A TENM4 DST NRXN1 HELZ2 MACF1 CAMTA1 PCNT | 3.15e-10 | 225 | 150 | 12 | 12168954 | |
| Pubmed | PSMC5 ACTN1 NSUN2 BIRC6 DST NF1 WDR6 MDC1 CLTC HELZ2 TJP2 MACF1 AATF SCAF11 MPHOSPH10 HERC2 DYNC1H1 PCNT | 5.33e-10 | 653 | 150 | 18 | 22586326 | |
| Pubmed | A central chaperone-like role for 14-3-3 proteins in human cells. | KDM5B RAPGEF6 DOCK11 KDM3B MCCC1 DNAH7 BMX CCDC88A DST NF1 AKAP9 PI4KB TJP2 RACGAP1 MACF1 NR3C2 PAN3 RAPGEF2 MAP3K21 KIF2C | 1.06e-09 | 861 | 150 | 20 | 36931259 |
| Pubmed | ANK2 SYNE1 TTC21A DGKB ACTN1 PLEKHA6 MTHFS ADD2 WDR47 TENM4 DST NF1 SACS CLU VCAN CLTC TJP2 MACF1 USP4 EXOC1 EIF3C RAPGEF2 DNM1 DYNC1H1 ATP5F1B | 2.59e-09 | 1431 | 150 | 25 | 37142655 | |
| Pubmed | HENA, heterogeneous network-based data set for Alzheimer's disease. | 2.82e-09 | 120 | 150 | 9 | 31413325 | |
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | EIF4A3 SYNE1 PSMC5 ACTN1 NSUN2 LIG3 DST NF1 SACS MDC1 CLTC TJP2 RACGAP1 MACF1 AATF LMAN2 EIF3C HERC2 DYNC1H1 ATP5F1B PCNT | 3.57e-09 | 1024 | 150 | 21 | 24711643 |
| Pubmed | SYNE1 DGKB ADCY6 PCDHB16 WDR47 TENM4 PXDN AKAP9 CLTC MACF1 CAMTA1 DYNC1H1 PCNT | 2.75e-08 | 407 | 150 | 13 | 12693553 | |
| Pubmed | Synaptic GAP and GEF Complexes Cluster Proteins Essential for GTP Signaling. | ANK2 SYNE1 ACTN1 BTBD9 NF1 SACS CLTC MACF1 RAPGEF2 DNM1 DYNC1H1 | 4.35e-08 | 281 | 150 | 11 | 28706196 |
| Pubmed | RAPGEF6 SPOPL FBXW12 ITGA9 ARID1B PSME4 PTPRR VCAN CLTC TJP2 MACF1 AATF LMAN2 MPHOSPH10 PAN3 CAMTA1 MAN1B1 RAD17 PCNT KIF2C | 4.96e-08 | 1084 | 150 | 20 | 11544199 | |
| Pubmed | APC2 DGKB ACTN1 MCCC1 ADD2 WDR47 NF1 PTPRN2 VCAN TJP2 MACF1 HERC2 RAPGEF2 | 5.21e-08 | 430 | 150 | 13 | 32581705 | |
| Pubmed | PSMB1 MRPS27 RANBP6 PSMC5 EXTL3 MCCC1 NSUN2 LIG3 DST PXDN CLU WDR6 MDC1 CLTC TJP2 RACGAP1 LMAN2 ACAA2 EXOC1 EIF3C RPA2 DYNC1H1 ATP5F1B | 6.21e-08 | 1440 | 150 | 23 | 30833792 | |
| Pubmed | ANK2 MRPS27 RABGAP1 MCCC1 IDH3G BIRC6 WDR47 CCDC88A TENM4 NF1 NRXN1 CLU CLTC FAM169A TJP2 SLC39A6 MACF1 EXOC1 EIF3C ATP5F1B | 1.10e-07 | 1139 | 150 | 20 | 36417873 | |
| Pubmed | RAPGEF6 KDM3B PAPSS2 NSUN2 ADCY6 LIG3 CCDC88A DST PSME4 CLU WDR6 RACGAP1 DNM1 RIOK2 MAN1B1 | 1.61e-07 | 650 | 150 | 15 | 38777146 | |
| Pubmed | Identification and proteomic analysis of distinct UBE3A/E6AP protein complexes. | 1.96e-07 | 58 | 150 | 6 | 22645313 | |
| Pubmed | SYNE1 ACTN1 EXTL3 PLEKHA6 CCDC88A DST CLTC KIAA1328 MACF1 HERC2 RAPGEF2 MAP3K21 SOS1 | 2.13e-07 | 486 | 150 | 13 | 20936779 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | MTIF3 KDM5B EIF4A3 SYNE1 MRPS27 ADD2 LIG3 ARID1B DST NRXN1 SACS VCAN CLTC HELZ2 MACF1 EIF3C PAN3 DNM1 DYNC1H1 | 2.35e-07 | 1082 | 150 | 19 | 38697112 |
| Pubmed | COL6A3 ANK2 SYNE1 BIRC6 ARID1B DST AKAP9 AGL CLTC MACF1 ACAA2 EXOC1 EIF3C | 2.74e-07 | 497 | 150 | 13 | 23414517 | |
| Pubmed | 2.96e-07 | 101 | 150 | 7 | 9872452 | ||
| Pubmed | A high-throughput approach for measuring temporal changes in the interactome. | EIF4A3 PSMB1 KDM3B RANBP6 PSMC5 RABGAP1 ACTN1 PAPSS2 NSUN2 BIRC6 PSME4 CLU AGL TJP2 MACF1 ACAA2 EIF3C DNM1 RPA2 DYNC1H1 DYNC1I2 ATP5F1B | 3.16e-07 | 1455 | 150 | 22 | 22863883 |
| Pubmed | RAPGEF6 DOCK11 BIRC6 ARID1B DST NF1 AKAP9 PI4KB TJP2 RAPGEF2 MAP3K21 KIF2C | 5.98e-07 | 446 | 150 | 12 | 24255178 | |
| Pubmed | 9.92e-07 | 76 | 150 | 6 | 27542412 | ||
| Pubmed | ANK2 EIF4A3 SYNE1 TAF1B ACTN1 ADCY6 DST PXDN NRXN1 IFT88 SACS SUGCT CSPG4 CLTC FAM169A MACF1 AATF MPHOSPH10 DYNC1I2 ATP5F1B PCNT | 1.10e-06 | 1442 | 150 | 21 | 35575683 | |
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | TTC21A PSMB1 PSMC5 ACTN1 ADCY6 MKS1 CCDC88A NF1 NRXN1 IFT88 PI4KB EXOC1 PAN3 NOPCHAP1 MAP3K21 RPA2 DYNC1H1 PKN3 DYNC1I2 KIF2C | 1.13e-06 | 1321 | 150 | 20 | 27173435 |
| Pubmed | KDM3B MCCC1 ACVR1B BIRC6 DNAH7 MKS1 LRIG2 CCDC88A DST PI4KB CLTC TJP2 RAPGEF2 DYNC1H1 FAM219A | 1.50e-06 | 777 | 150 | 15 | 35844135 | |
| Pubmed | 1.58e-06 | 251 | 150 | 9 | 27507650 | ||
| Pubmed | A High-Density Human Mitochondrial Proximity Interaction Network. | MTIF3 SYNE1 PSMB1 MRPS27 RANBP6 PSMC5 RABGAP1 BIRC6 DST AKAP9 WDR6 CLTC FAM169A AATF ACAA2 MPHOSPH10 HERC2 RPA2 ATP5F1B PCNT KIF2C | 1.97e-06 | 1496 | 150 | 21 | 32877691 |
| Pubmed | 1.97e-06 | 332 | 150 | 10 | 37433992 | ||
| Pubmed | High-throughput analyses of hnRNP H1 dissects its multi-functional aspect. | KCTD9 MECOM PLEKHA6 NSUN2 ADCY6 SLC25A37 TTC7A PSME4 SUGCT WDR6 CSPG4 LMAN2 CALML4 PAN3 CAMTA1 FAM219A ZNF345 | 2.18e-06 | 1021 | 150 | 17 | 26760575 |
| Pubmed | KDM5B RAPGEF6 ZSCAN4 MECOM RABGAP1 MCCC1 BIRC6 CCDC88A DST WDR6 PCNT | 2.22e-06 | 418 | 150 | 11 | 34709266 | |
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | EIF4A3 SYNE1 PSMB1 ACTN1 MCCC1 PAPSS2 NSUN2 GSTM4 ARID1B DST AKAP9 CLTC MACF1 DYNC1H1 ATP5F1B | 2.39e-06 | 807 | 150 | 15 | 30575818 |
| Pubmed | 2.62e-06 | 199 | 150 | 8 | 36688959 | ||
| Pubmed | 2.92e-06 | 347 | 150 | 10 | 17114649 | ||
| Pubmed | PSMC5 BIRC6 ADD2 ARID1B CCDC88A AKAP9 PTPRN2 PTPRR CLTC KIAA1328 SLC39A6 AATF EIF3C HERC2 SUFU RPA2 PCNT | 3.13e-06 | 1049 | 150 | 17 | 27880917 | |
| Pubmed | Reciprocal interaction between SIRT6 and APC/C regulates genomic stability. | DOCK11 NSUN2 ARID1B NF1 WDR6 MDC1 CLTC AATF MPHOSPH10 HERC2 RPA2 | 3.62e-06 | 440 | 150 | 11 | 34244565 |
| Pubmed | PCGF1 PSMB1 MRPS27 PSMC5 MECOM MCCC1 NSUN2 LIG3 ARID1B DST MDC1 RACGAP1 SCAF11 SPOP EIF3C HERC2 PAN3 SUFU RPA2 DYNC1H1 | 3.69e-06 | 1429 | 150 | 20 | 35140242 | |
| Pubmed | 4.04e-06 | 360 | 150 | 10 | 33111431 | ||
| Pubmed | Region-specific saturation germline mutagenesis in mice using the Sleeping Beauty transposon system. | 4.33e-06 | 8 | 150 | 3 | 16179923 | |
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | PSMB1 MRPS27 RANBP6 PSMC5 LRIG2 PTPRN2 PTPRR WDR6 AGL TJP2 EIF3C PIPSL SUFU MAN1B1 ATP5F1B KIF2C | 5.24e-06 | 974 | 150 | 16 | 28675297 |
| Pubmed | EIF4A3 PSMB1 PSMC5 ACTN1 NSUN2 LIG3 DST MDC1 CLTC RACGAP1 MACF1 EIF3C RPA2 | 6.26e-06 | 660 | 150 | 13 | 32780723 | |
| Pubmed | Mapping the NPHP-JBTS-MKS protein network reveals ciliopathy disease genes and pathways. | PSMB1 PSMC5 ACTN1 MKS1 PSME4 IFT88 VCAN ACAA2 EXOC1 DNM1 ATP5F1B KIF2C | 6.69e-06 | 564 | 150 | 12 | 21565611 |
| Pubmed | MED18 ANK2 TAF1B MRPS27 NSUN2 AKAP9 WDR6 AGL CLTC HELZ2 TJP2 RACGAP1 AATF SCAF11 HERC2 PIPSL RIOK2 DYNC1H1 ATP5F1B | 7.59e-06 | 1371 | 150 | 19 | 36244648 | |
| Pubmed | EB1-binding-myomegalin protein complex promotes centrosomal microtubules functions. | 8.02e-06 | 63 | 150 | 5 | 29162697 | |
| Pubmed | 8.58e-06 | 167 | 150 | 7 | 22159717 | ||
| Pubmed | 9.23e-06 | 10 | 150 | 3 | 23885123 | ||
| Pubmed | ZSCAN4 KDM3B RANBP6 TINAGL1 ARID1B DST CSPG4 MACF1 EIF3C MPHOSPH10 HERC2 DYNC1H1 | 1.07e-05 | 591 | 150 | 12 | 15231748 | |
| Pubmed | TNIP2 is a Hub Protein in the NF-κB Network with Both Protein and RNA Mediated Interactions. | EIF4A3 PSMB1 PSMC5 MECOM BTBD9 ARID1B WDR6 CLTC LMAN2 ACAA2 MPHOSPH10 HERC2 MAP3K21 DYNC1I2 ATP5F1B | 1.17e-05 | 922 | 150 | 15 | 27609421 |
| Pubmed | 1.18e-05 | 322 | 150 | 9 | 26514267 | ||
| Pubmed | N-Terminal Acetyltransferase Naa40p Whereabouts Put into N-Terminal Proteoform Perspective. | RAPGEF6 ANK2 KDM3B PSMC5 MCCC1 NSUN2 LIG3 DST FAM169A MACF1 EIF3C NOPCHAP1 PKN3 ATP5F1B PCNT | 1.37e-05 | 934 | 150 | 15 | 33916271 |
| Pubmed | 1.57e-05 | 35 | 150 | 4 | 30257870 | ||
| Pubmed | 1.61e-05 | 255 | 150 | 8 | 15324660 | ||
| Pubmed | TBK1 phosphorylation activates LIR-dependent degradation of the inflammation repressor TNIP1. | EIF4A3 SYNE1 ACTN1 NSUN2 DST PXDN MDC1 CLTC RACGAP1 AATF EIF3C MPHOSPH10 RIOK2 DYNC1H1 KIF2C | 1.64e-05 | 949 | 150 | 15 | 36574265 |
| Pubmed | Spop regulates Gli3 activity and Shh signaling in dorsoventral patterning of the mouse spinal cord. | 1.68e-05 | 12 | 150 | 3 | 28412462 | |
| Pubmed | Cofilin and Vangl2 cooperate in the initiation of planar cell polarity in the mouse embryo. | 1.68e-05 | 12 | 150 | 3 | 23406901 | |
| Pubmed | KCTD9 PCGF1 EIF4A3 APC2 KDM3B DGKB ACVR1B CES2 ARID1B USP4 CALML4 EIF3C DNM1 | 1.82e-05 | 730 | 150 | 13 | 34857952 | |
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 17900358 | ||
| Pubmed | Pathological angiogenesis is reduced by targeting pericytes via the NG2 proteoglycan. | 1.85e-05 | 2 | 150 | 2 | 15609081 | |
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 30635602 | ||
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 11002341 | ||
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 23583712 | ||
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 25943950 | ||
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 24858808 | ||
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 29955124 | ||
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 34239347 | ||
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 16740475 | ||
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 20399258 | ||
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 16625365 | ||
| Pubmed | Roadkill attenuates Hedgehog responses through degradation of Cubitus interruptus. | 1.85e-05 | 2 | 150 | 2 | 16651542 | |
| Pubmed | 1.85e-05 | 2 | 150 | 2 | 32600317 | ||
| Pubmed | Two-Dimensional Fractionation Method for Proteome-Wide Cross-Linking Mass Spectrometry Analysis. | EIF4A3 PSMC5 RABGAP1 ACTN1 IDH3G LIG3 CLTC MACF1 EIF3C PIPSL DYNC1H1 DYNC1I2 ATP5F1B PCNT | 1.96e-05 | 847 | 150 | 14 | 35235311 |
| Pubmed | Cell-Type-Specific Alternative Splicing Governs Cell Fate in the Developing Cerebral Cortex. | 1.97e-05 | 37 | 150 | 4 | 27565344 | |
| Pubmed | 2.05e-05 | 191 | 150 | 7 | 33762435 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | TRPM4 RAPGEF6 KDM3B EXTL3 BIRC6 TINAGL1 DST PSME4 CSPG4 HELZ2 HERC2 SUFU DYNC1H1 PKN3 CREB3 PCNT | 2.47e-05 | 1105 | 150 | 16 | 35748872 |
| Pubmed | 2.58e-05 | 198 | 150 | 7 | 27480124 | ||
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | EIF4A3 TAF1B MRPS27 NSUN2 BIRC6 LIG3 RACGAP1 MACF1 AATF SCAF11 MPHOSPH10 HERC2 KIF2C | 2.72e-05 | 759 | 150 | 13 | 35915203 |
| Pubmed | The contribution of rare and common variants in 30 genes to risk nicotine dependence. | 2.76e-05 | 14 | 150 | 3 | 25450229 | |
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | 2.77e-05 | 135 | 150 | 6 | 28675934 | |
| Pubmed | Physiological and pathophysiological characteristics of ataxin-3 isoforms. | 3.21e-05 | 281 | 150 | 8 | 30455355 | |
| Pubmed | Targeting USP10 induces degradation of oncogenic ANLN in esophageal squamous cell carcinoma. | EIF4A3 MRPS27 ACTN1 NSUN2 DST WDR6 MDC1 CLTC HELZ2 TJP2 RACGAP1 AATF SCAF11 MPHOSPH10 DYNC1H1 ATP5F1B KIF2C | 3.22e-05 | 1257 | 150 | 17 | 36526897 |
| Pubmed | C9orf72 protein quality control by UBR5-mediated heterotypic ubiquitin chains. | HLA-DQB1 EIF4A3 PSMB1 PSMC5 IDH3G NSUN2 BIRC6 PSME4 WDR6 AGL CLTC EIF3C PIPSL RPA2 DYNC1H1 DYNC1I2 ATP5F1B | 3.22e-05 | 1257 | 150 | 17 | 37317656 |
| Pubmed | Tau interactome maps synaptic and mitochondrial processes associated with neurodegeneration. | ANK2 PSMC5 ACTN1 ADD2 WDR47 TTC7A AGL CLTC SLC39A6 DNM1 DYNC1H1 | 3.29e-05 | 558 | 150 | 11 | 35063084 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | RAPGEF6 KDM3B NSUN2 ADCY6 NF1 MDC1 CLTC HELZ2 TJP2 SCAF11 EIF3C DYNC1I2 SOS1 | 3.33e-05 | 774 | 150 | 13 | 15302935 |
| Pubmed | 3.44e-05 | 15 | 150 | 3 | 18303054 | ||
| Pubmed | 3.60e-05 | 371 | 150 | 9 | 15747579 | ||
| Pubmed | Charting the landscape of tandem BRCT domain-mediated protein interactions. | MTIF3 PSMC5 CCDC88A CLU WDR6 MDC1 CLTC SCAF11 DYNC1H1 DYNC1I2 PCNT KIF2C | 3.65e-05 | 670 | 150 | 12 | 22990118 |
| Pubmed | Assembly of the U5 snRNP component PRPF8 is controlled by the HSP90/R2TP chaperones. | EIF4A3 PSMB1 MRPS27 ACTN1 PAPSS2 NSUN2 BIRC6 AGL MDC1 CLTC MACF1 SCAF11 EIF3C RIOK2 DYNC1H1 DYNC1I2 MAN1B1 ATP5F1B | 4.14e-05 | 1415 | 150 | 18 | 28515276 |
| Pubmed | RFWD3-Dependent Ubiquitination of RPA Regulates Repair at Stalled Replication Forks. | 4.23e-05 | 16 | 150 | 3 | 26474068 | |
| Pubmed | Quantitative proteomics identifies a Dab2/integrin module regulating cell migration. | 4.32e-05 | 45 | 150 | 4 | 19581412 | |
| Pubmed | 4.46e-05 | 147 | 150 | 6 | 29576527 | ||
| Pubmed | Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation. | EIF4A3 SYNE1 PSMB1 MRPS27 PSMC5 IDH3G NSUN2 LIG3 NF1 WDR6 MDC1 CLTC RACGAP1 LMAN2 EIF3C RPA2 DYNC1H1 ATP5F1B | 4.53e-05 | 1425 | 150 | 18 | 30948266 |
| Pubmed | EIF4A3 ACTN1 MCCC1 WDR6 CLTC LMAN2 EIF3C RPA2 DYNC1H1 ATP5F1B | 5.12e-05 | 484 | 150 | 10 | 31995728 | |
| Pubmed | KCTD9 EIF4A3 MRPS27 PSMC5 NSUN2 CLTC EXOC1 EIF3C RPA2 DYNC1H1 DYNC1I2 ATP5F1B KIF2C | 5.22e-05 | 809 | 150 | 13 | 32129710 | |
| Pubmed | 5.53e-05 | 3 | 150 | 2 | 19859085 | ||
| Pubmed | Expression of the mouse Macf2 gene during inner ear development. | 5.53e-05 | 3 | 150 | 2 | 12399109 | |
| Pubmed | 5.53e-05 | 3 | 150 | 2 | 9478994 | ||
| Pubmed | 5.53e-05 | 3 | 150 | 2 | 39408701 | ||
| Pubmed | 5.53e-05 | 3 | 150 | 2 | 23798705 | ||
| Interaction | DSCAM interactions | SYNE1 APC2 ACTN1 DST IFT88 SACS CLU CLTC MACF1 EIF3C DYNC1H1 ATP5F1B | 4.35e-09 | 171 | 146 | 12 | int:DSCAM |
| Interaction | TNIK interactions | KCTD9 ANK2 DOCK11 SYNE1 DST AKAP9 CLU PI4KB MACF1 HERC2 DNM1 RPA2 DYNC1H1 KIF2C SOS1 | 1.20e-07 | 381 | 146 | 15 | int:TNIK |
| Interaction | MAPRE1 interactions | EIF4A3 PSMB1 APC2 ACTN1 NSUN2 CCDC88A DST AKAP9 CLTC MACF1 USP4 HERC2 RPA2 DYNC1H1 DYNC1I2 PCNT KIF2C | 2.01e-07 | 514 | 146 | 17 | int:MAPRE1 |
| Interaction | YWHAQ interactions | KCTD9 KDM5B RAPGEF6 DOCK11 EIF4A3 MRPS27 MCCC1 DNAH7 CCDC88A DST NF1 NRXN1 PI4KB CLTC TJP2 RACGAP1 MACF1 SPOP PAN3 RAPGEF2 MAP3K21 RPA2 DYNC1H1 DYNC1I2 ATP5F1B | 4.50e-07 | 1118 | 146 | 25 | int:YWHAQ |
| Interaction | DISC1 interactions | EIF4A3 SYNE1 RABGAP1 ACTN1 CCDC88A DST AKAP9 CLU TJP2 MACF1 EXOC1 HERC2 SUFU DYNC1H1 PCNT | 5.47e-07 | 429 | 146 | 15 | int:DISC1 |
| Interaction | AGAP2 interactions | 3.15e-06 | 210 | 146 | 10 | int:AGAP2 | |
| Interaction | PFN1 interactions | RAPGEF6 ANK2 RABGAP1 BIRC6 NF1 AKAP9 CLTC TJP2 MACF1 USP4 ACAA2 SPOP DNM1 RPA2 PCNT | 4.51e-06 | 509 | 146 | 15 | int:PFN1 |
| Interaction | SIRT7 interactions | PSMC5 ACTN1 NSUN2 BIRC6 DST NF1 WDR6 MDC1 CLTC HELZ2 TJP2 MACF1 AATF SCAF11 MPHOSPH10 HERC2 DYNC1H1 PCNT | 7.54e-06 | 744 | 146 | 18 | int:SIRT7 |
| Interaction | CLIP1 interactions | PCGF1 BIRC6 CCDC88A AKAP9 ACAA2 DYNC1H1 DYNC1I2 ATP5F1B KIF2C | 7.66e-06 | 183 | 146 | 9 | int:CLIP1 |
| Interaction | PHF21A interactions | RAPGEF6 MECOM RABGAP1 MCCC1 BIRC6 CCDC88A DST WDR6 EXOC1 RPA2 PKN3 PCNT | 7.80e-06 | 343 | 146 | 12 | int:PHF21A |
| Interaction | PCNT interactions | 1.06e-05 | 241 | 146 | 10 | int:PCNT | |
| Interaction | DSCR9 interactions | 1.19e-05 | 147 | 146 | 8 | int:DSCR9 | |
| Interaction | YWHAH interactions | KDM5B RAPGEF6 DOCK11 KDM3B DNAH7 CCDC88A DST NF1 AKAP9 PI4KB TJP2 RACGAP1 MACF1 USP4 NR3C2 SPOP PAN3 RAPGEF2 MAP3K21 RPA2 PCNT KIF2C | 1.46e-05 | 1102 | 146 | 22 | int:YWHAH |
| Interaction | SLC6A4 interactions | APC2 DGKB ACTN1 MCCC1 ADD2 WDR47 NF1 PTPRN2 VCAN TJP2 MACF1 HERC2 RAPGEF2 | 1.83e-05 | 437 | 146 | 13 | int:SLC6A4 |
| Interaction | UBE3A interactions | PSMB1 PSMC5 NSUN2 PSME4 SACS CLU CLTC PPP1R3F NR3C2 EIF3C HERC2 PIPSL RPA2 | 2.01e-05 | 441 | 146 | 13 | int:UBE3A |
| Interaction | KCTD13 interactions | ANK2 SYNE1 TTC21A DGKB ACTN1 PLEKHA6 BTBD9 MTHFS ADD2 WDR47 TENM4 DST NF1 SACS CLU VCAN CLTC TJP2 MACF1 USP4 EXOC1 RAPGEF2 DNM1 DYNC1H1 ATP5F1B | 2.22e-05 | 1394 | 146 | 25 | int:KCTD13 |
| Interaction | ATOH1 interactions | 2.52e-05 | 80 | 146 | 6 | int:ATOH1 | |
| Interaction | YWHAZ interactions | KCTD9 KDM5B RAPGEF6 DOCK11 CCDC88A DST NF1 AKAP9 NRXN1 PI4KB MDC1 CLTC TJP2 RACGAP1 MACF1 SCAF11 SPOP HERC2 RAPGEF2 MAP3K21 RPA2 DYNC1H1 ATP5F1B PCNT | 2.62e-05 | 1319 | 146 | 24 | int:YWHAZ |
| Interaction | PDLIM5 interactions | SPOPL EIF4A3 ACTN1 BIRC6 TJP2 USP4 RAPGEF2 RPA2 DYNC1H1 SOS1 | 3.10e-05 | 273 | 146 | 10 | int:PDLIM5 |
| Interaction | YWHAG interactions | KDM5B RAPGEF6 DOCK11 KDM3B DNAH7 CCDC88A DST NF1 AKAP9 PI4KB CLTC TJP2 RACGAP1 MACF1 SCAF11 ACAA2 SPOP PAN3 RAPGEF2 MAP3K21 DYNC1H1 ATP5F1B KIF2C | 3.24e-05 | 1248 | 146 | 23 | int:YWHAG |
| Interaction | SFN interactions | RAPGEF6 DOCK11 ACTN1 CCDC88A DST AKAP9 PI4KB CLTC TJP2 RACGAP1 MACF1 USP4 EIF3C PAN3 MAP3K21 RPA2 | 4.32e-05 | 692 | 146 | 16 | int:SFN |
| Interaction | THOC5 interactions | 4.78e-05 | 131 | 146 | 7 | int:THOC5 | |
| Interaction | SH3BP5 interactions | 6.26e-05 | 30 | 146 | 4 | int:SH3BP5 | |
| Interaction | TRAF3IP1 interactions | 7.07e-05 | 96 | 146 | 6 | int:TRAF3IP1 | |
| Interaction | BTG3 interactions | 7.94e-05 | 98 | 146 | 6 | int:BTG3 | |
| Interaction | SYNGAP1 interactions | ANK2 BTBD9 BIRC6 CCDC88A CLTC RAPGEF2 DNM1 RPA2 DYNC1H1 PCNT | 8.29e-05 | 307 | 146 | 10 | int:SYNGAP1 |
| Interaction | EXOC1 interactions | 8.34e-05 | 143 | 146 | 7 | int:EXOC1 | |
| Interaction | CCDC8 interactions | NSUN2 LIG3 DST NF1 SACS PTPRN2 CLTC MACF1 LMAN2 EIF3C HERC2 RPA2 DYNC1H1 ATP5F1B PCNT | 8.58e-05 | 656 | 146 | 15 | int:CCDC8 |
| Interaction | BMI1 interactions | PCGF1 EIF4A3 SYNE1 ACTN1 DST AKAP9 CLTC HELZ2 SCAF11 SPOP EIF3C RPA2 DYNC1H1 MAN1B1 ATP5F1B | 9.02e-05 | 659 | 146 | 15 | int:BMI1 |
| Interaction | MOB4 interactions | 1.12e-04 | 150 | 146 | 7 | int:MOB4 | |
| Interaction | CALD1 interactions | 1.38e-04 | 265 | 146 | 9 | int:CALD1 | |
| Interaction | NUDC interactions | 1.78e-04 | 337 | 146 | 10 | int:NUDC | |
| Interaction | HAX1 interactions | ANK2 MECOM RABGAP1 CLU WDR6 CLTC DNM1 PKN3 ATP5F1B PCNT KIF2C | 1.79e-04 | 404 | 146 | 11 | int:HAX1 |
| Interaction | DYRK1A interactions | MED18 MCCC1 NSUN2 WDR47 NF1 CLU CLTC TJP2 RACGAP1 PPP1R3F RAPGEF2 DNM1 PCNT | 1.94e-04 | 552 | 146 | 13 | int:DYRK1A |
| Interaction | NDEL1 interactions | 1.96e-04 | 164 | 146 | 7 | int:NDEL1 | |
| GeneFamily | Type 1 receptor serine/threonine kinases | 7.01e-04 | 7 | 106 | 2 | 345 | |
| GeneFamily | EF-hand domain containing|Plakins | 9.32e-04 | 8 | 106 | 2 | 939 | |
| Coexpression | HALLMARK_MITOTIC_SPINDLE | RAPGEF6 RABGAP1 CCDC88A DST NF1 RACGAP1 DYNC1H1 PCNT KIF2C SOS1 | 2.22e-07 | 199 | 149 | 10 | M5893 |
| Coexpression | MENON_FETAL_KIDNEY_3_STROMAL_CELLS | 4.07e-07 | 81 | 149 | 7 | M39253 | |
| Coexpression | SENESE_HDAC1_AND_HDAC2_TARGETS_UP | 1.10e-05 | 243 | 149 | 9 | M18938 | |
| Coexpression | WU_SILENCED_BY_METHYLATION_IN_BLADDER_CANCER | 1.16e-05 | 52 | 149 | 5 | M19766 | |
| Coexpression | GSE11864_CSF1_VS_CSF1_PAM3CYS_IN_MAC_UP | 1.78e-05 | 197 | 149 | 8 | M3136 | |
| Coexpression | GSE14350_TREG_VS_TEFF_UP | 1.91e-05 | 199 | 149 | 8 | M3417 | |
| Coexpression | GSE22886_IGG_IGA_MEMORY_BCELL_VS_BLOOD_PLASMA_CELL_UP | 1.91e-05 | 199 | 149 | 8 | M4444 | |
| Coexpression | SENESE_HDAC3_TARGETS_UP | TRPM4 SFRP1 CHRNA9 EXTL3 SLC25A37 CCDC88A DST NF1 PSME4 PTPRR WDR6 SLC39A6 | 2.76e-05 | 495 | 149 | 12 | M8451 |
| Coexpression | GSE4590_SMALL_VS_VPREB_POS_LARGE_PRE_BCELL_UP | 5.13e-05 | 168 | 149 | 7 | M6874 | |
| Coexpression | GSE9601_UNTREATED_VS_NFKB_INHIBITOR_TREATED_HCMV_INF_MONOCYTE_DN | 6.40e-05 | 174 | 149 | 7 | M6881 | |
| Coexpression | GCNP_SHH_UP_LATE.V1_UP | 8.20e-05 | 181 | 149 | 7 | M2641 | |
| CoexpressionAtlas | Myeloid Cells, DC.8-4-11b-.SLN, CD45-APC CD11b-FITC CD11c-eFluor780 CD4-PE CD8a-eF, Lymph Node, avg-1 | 1.95e-05 | 81 | 145 | 6 | GSM854290_100 | |
| CoexpressionAtlas | Myeloid Cells, DC.IIhilang-103-11blo.SLN, MHCIIhi CD11c+ Langerin- CD103- CD11b-, Lymph Node, avg-3 | 2.09e-05 | 82 | 145 | 6 | GSM538277_100 | |
| CoexpressionAtlas | Myeloid Cells, DC.8-4-11b+.SLN, CD45-APC CD11b-FITC CD11c-eFluor780 CD4-PE CD8a-eF, Lymph Node, avg-2 | 2.24e-05 | 83 | 145 | 6 | GSM854285_100 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000 | COL6A3 SFRP1 ACTN1 ACVR1C ITGA9 PAPSS2 TINAGL1 GSTM4 TENM4 CLU VCAN MDC1 RACGAP1 ACAA2 CALML4 DNM1 KIF2C | 3.03e-05 | 793 | 145 | 17 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_1000 |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_top-relative-expression-ranked_500 | COL6A3 SFRP1 ACVR1C ITGA9 PAPSS2 TENM4 CLU VCAN ACAA2 CALML4 DNM1 | 5.26e-05 | 373 | 145 | 11 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_500 |
| ToppCell | COVID-19-Fibroblasts-Airway_smooth_muscle|COVID-19 / group, cell type (main and fine annotations) | 8.54e-10 | 187 | 150 | 10 | 464a0c3b92b778911b5f9cd73642e09e3472063a | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.71e-09 | 167 | 150 | 9 | f01b96173deda0239fa482989873cf308e49d48c | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_mature|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 5.71e-09 | 167 | 150 | 9 | 5fc85a05124cd2324e1b8ff940193880f83cd8af | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.20e-08 | 195 | 150 | 9 | 7796ea9247f4c63762f0de8490fed08b9717fa23 | |
| ToppCell | Tracheal-NucSeq|Tracheal / Cell types per location group and 10X technology with lineage, and cell group designations | 2.62e-08 | 199 | 150 | 9 | 94b94b17ca18b8dc27b91da1f2ccf89e03cc7035 | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_perichondrial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.62e-08 | 199 | 150 | 9 | abd6117f8a3d7e798d8471c16d97b34aaf50fc9c | |
| ToppCell | droplet-Lung-LUNG-1m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.34e-07 | 186 | 150 | 8 | 1e67bfb248366d7395efdd2d5e70a97bdb2e68af | |
| ToppCell | facs-Lung-3m-Endothelial-arterial_endothelial|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.86e-07 | 191 | 150 | 8 | 6e6b2cb390cc5cd0356924a2c36fbe5b5bd5966c | |
| ToppCell | facs-Lung-3m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.86e-07 | 191 | 150 | 8 | 482db995930346be69072ace2fd78fd453e97fb5 | |
| ToppCell | droplet-Pancreas-PANCREAS-30m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.35e-07 | 195 | 150 | 8 | 3e519cffa6144a62b06124642a14c9ff39b76554 | |
| ToppCell | Bronchial-NucSeq|Bronchial / Cell types per location group and 10X technology with lineage, and cell group designations | 3.48e-07 | 196 | 150 | 8 | ab53c742866945545a92e2e61850d63c80d9a2a6 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.62e-07 | 197 | 150 | 8 | 6d0d68d460243a0259ada93ebda40fa7b3088eeb | |
| ToppCell | Parenchymal-NucSeq|Parenchymal / Cell types per location group and 10X technology with lineage, and cell group designations | 3.76e-07 | 198 | 150 | 8 | 1996373bdccc55aac347d349bd22f6aad6d0c668 | |
| ToppCell | LPS_anti-TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_anti-TNF / Treatment groups by lineage, cell group, cell type | 4.06e-07 | 200 | 150 | 8 | 9b0916d8d07ac2bf1739f7be5296bf77ffee6094 | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_perichondrial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.06e-07 | 200 | 150 | 8 | a4ec0e80f5422b91b85264a9bb74568dd577e285 | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.55e-06 | 166 | 150 | 7 | 7a45785a40b7425f97be67bab1c5ceb69b2bd85a | |
| ToppCell | PND14-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.55e-06 | 166 | 150 | 7 | bbd382812f8a84a5d99888de2d7cca3a8b5e4695 | |
| ToppCell | COVID-19-kidney-PEC|kidney / Disease (COVID-19 only), tissue and cell type | 1.96e-06 | 172 | 150 | 7 | 36a96714a0eb6ac438648135336c9791881ddadb | |
| ToppCell | facs-Lung-3m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.46e-06 | 178 | 150 | 7 | 9f59a9af232d77bb55603a7776dbf9749ea652f2 | |
| ToppCell | COVID-19-kidney-Epi_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 2.56e-06 | 179 | 150 | 7 | e7c9dc63f03d3f3746b51a7e3c8393089e2ceb7d | |
| ToppCell | droplet-Lung-21m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.85e-06 | 182 | 150 | 7 | c7f2d24697affa530b748ab32b1d40bdc1bdc20a | |
| ToppCell | droplet-Lung-21m-Endothelial-arterial_endothelial|21m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.85e-06 | 182 | 150 | 7 | d95635b74e8cd8bc00bfe40340806b59fb9bee43 | |
| ToppCell | facs-Lung-Endomucin-3m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.85e-06 | 182 | 150 | 7 | aa113a0d2c1d28bda24cbb1221afd21b5628dc6d | |
| ToppCell | facs-Lung-nan-3m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.96e-06 | 183 | 150 | 7 | 12e876d6205af8aad74265c668b5e95b9e7487f3 | |
| ToppCell | PND07-28-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_C|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 3.18e-06 | 185 | 150 | 7 | 427176ad9ab8d9511200fb0a132cfd1e835fe35c | |
| ToppCell | droplet-Lung-1m-Endothelial-arterial_endothelial|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.29e-06 | 186 | 150 | 7 | ffbc78058be8f0dc2e0335cc4c3195a636d17721 | |
| ToppCell | droplet-Lung-1m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.29e-06 | 186 | 150 | 7 | ed924852cd7132c8f6703522037dc22bd2c83193 | |
| ToppCell | metastatic_Lymph_Node-Endothelial_cells-Tumor_ECs|metastatic_Lymph_Node / Location, Cell class and cell subclass | 3.41e-06 | 187 | 150 | 7 | 2713f526f86911fbbf6c7a3e69230f2e6bde31c3 | |
| ToppCell | droplet-Lung-18m-Endothelial-arterial_endothelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.41e-06 | 187 | 150 | 7 | 12129e02638c20d9b7c1c6e512d48bfd966e1029 | |
| ToppCell | droplet-Lung-18m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.41e-06 | 187 | 150 | 7 | 83930ef55191eff9006113feaeabb3c2fa21fd05 | |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | 3.41e-06 | 187 | 150 | 7 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 | |
| ToppCell | 10x5'-GI_small-bowel-Lymphocytic_T_CD4-T_CD4/CD8|GI_small-bowel / Manually curated celltypes from each tissue | 3.54e-06 | 188 | 150 | 7 | ab9b725d6e0cdab8e9ddda6dee09e14730e9a578 | |
| ToppCell | P28-Endothelial-large_vessel_endothelial_cell|P28 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 3.54e-06 | 188 | 150 | 7 | 263169029293e005bcffd87db20221fdd2d3917e | |
| ToppCell | droplet-Lung-1m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27|1m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.79e-06 | 190 | 150 | 7 | 3b9abc25b17e7295356ded57ff2ca519fa9f2686 | |
| ToppCell | COVID-19-Heart-EC_(POSTN)|Heart / Disease (COVID-19 only), tissue and cell type | 4.06e-06 | 192 | 150 | 7 | c0c34785a7bdf461722029b322e9184e3d9b3c26 | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 4.06e-06 | 192 | 150 | 7 | 60b1312e84f6d6448365a952469c506c00b5fe93 | |
| ToppCell | RV-10._Endothelium_II|RV / Chamber and Cluster_Paper | 4.20e-06 | 193 | 150 | 7 | 01c2df9206f1527c578e808978e58196c35e72f5 | |
| ToppCell | TCGA-Prostate-Primary_Tumor-Prostate_Adenocarcinoma-Acinar_Adenocarcinoma-6|TCGA-Prostate / Sample_Type by Project: Shred V9 | 4.20e-06 | 193 | 150 | 7 | abd71b2cf667ef2b1c4d88acd0c1dd19a12ff659 | |
| ToppCell | COVID-19-Fibroblasts-Other_FB|COVID-19 / group, cell type (main and fine annotations) | 4.20e-06 | 193 | 150 | 7 | e6b75be08e33c1de079fb5c02f0b4468128b369c | |
| ToppCell | Control-Endothelial-VE_Arterial|World / Disease state, Lineage and Cell class | 4.20e-06 | 193 | 150 | 7 | 52c0f2c7af57436f23e0c0e0c87086c47695e2c4 | |
| ToppCell | P15-Endothelial-large_vessel_endothelial_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 4.20e-06 | 193 | 150 | 7 | 5f9a7cd5f8eb9ac294cdb50518fedf872f3f78f5 | |
| ToppCell | Control-Fibroblasts-Intermediate_pathological_FB|Control / group, cell type (main and fine annotations) | 4.35e-06 | 194 | 150 | 7 | 03a269f75a481ea54aea8e6444605db8d6df493d | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 4.35e-06 | 194 | 150 | 7 | 4d6c9b016e3a0641954a8ea10c97d1cd76fadd9f | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_fibro-stroma-endosteal_fibroblast|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 4.35e-06 | 194 | 150 | 7 | 69362e13158033de44f90f3773db6c0f27de8cb3 | |
| ToppCell | Control-Endothelial-VE_Arterial|Control / Disease state, Lineage and Cell class | 4.50e-06 | 195 | 150 | 7 | 56c66a3655820961e1390b8f4bcc5618e8d0c5a8 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.65e-06 | 196 | 150 | 7 | 1450cb69c5bf469e97c03bf1890f6f7c54165b8a | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature3_(17)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.81e-06 | 197 | 150 | 7 | 31a1852911bda38543916585fda34255fd62a134 | |
| ToppCell | COVID-19-Fibroblasts-Intermediate_pathological_FB|COVID-19 / group, cell type (main and fine annotations) | 4.81e-06 | 197 | 150 | 7 | f1c8936986123a3151140c374fcd62d6705c530b | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.81e-06 | 197 | 150 | 7 | 44673c38384453207871d3fd8e8ba9093cc06bc5 | |
| ToppCell | Monocytes-NUPR1+_Monocytes|Monocytes / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 4.81e-06 | 197 | 150 | 7 | 8a058c9d9285acd7cf2fb8e34f7602a86b5d6c89 | |
| ToppCell | PCW_13-14-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_13-14 / Celltypes from embryonic and fetal-stage human lung | 4.81e-06 | 197 | 150 | 7 | 0034bae02ee7fcfea520d453ca3c842ab6963b12 | |
| ToppCell | Bronchial-NucSeq-Stromal-Peri/Epineurial_|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 4.81e-06 | 197 | 150 | 7 | ee8f7def9d5af7b1e636830a4ea1da158d02f25a | |
| ToppCell | COVID-19-Fibroblasts|COVID-19 / group, cell type (main and fine annotations) | 4.81e-06 | 197 | 150 | 7 | fb847f2277609c31fffcdf49517243ce0684facf | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic-mes_immature1_(0)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 4.81e-06 | 197 | 150 | 7 | 11a4c417f035e554431a8f03be13b5eefa3530c0 | |
| ToppCell | IPF-Stromal-Myofibroblast|Stromal / Disease state, Lineage and Cell class | 4.81e-06 | 197 | 150 | 7 | f304d42fc4936fe20996e07c8dccc698a6e5e5ef | |
| ToppCell | Primary_Visual_cortex_(V1C)-Neuronal|Primary_Visual_cortex_(V1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.97e-06 | 198 | 150 | 7 | 8ab40fae14fe02e39bc8c8da187a5cd60c787643 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_fibroblastic|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 4.97e-06 | 198 | 150 | 7 | 17dc055e2a289496d9c5cdbf3297bdf906dc6d22 | |
| ToppCell | Primary_Motor_Cortex_(M1)-Neuronal|Primary_Motor_Cortex_(M1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 4.97e-06 | 198 | 150 | 7 | 4ca5ff320905ab4ff60ed90a5522227c782142a6 | |
| ToppCell | (00)_Basal-(2)_GFP_FOXI1|(00)_Basal / shred by cell type by condition | 5.14e-06 | 199 | 150 | 7 | 19674e1eaeb51e4196d847cb62aa437c852951d3 | |
| ToppCell | LPS_IL1RA-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA / Treatment groups by lineage, cell group, cell type | 5.14e-06 | 199 | 150 | 7 | a7dd94b172c973a131a6792f8ccd9bfe44d984ac | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 5.14e-06 | 199 | 150 | 7 | 30d3e8c0681ec11f86dd38c5f48d21187a1b4f90 | |
| ToppCell | Tracheal-NucSeq-Stromal-Chondrocytic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.31e-06 | 200 | 150 | 7 | b5a54b9baf79aea01f76a161f0a39bbe87eb4945 | |
| ToppCell | Tracheal-NucSeq-Stromal-Chondrocytic-Chondrocyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.31e-06 | 200 | 150 | 7 | f5bd0b30e478dac09f68c46b0781f5f2e7e3c693 | |
| ToppCell | mild|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class | 5.31e-06 | 200 | 150 | 7 | 12f1685ce8f218433068e090c9d839cd5a1910bf | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic-Fibroblasts|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 5.31e-06 | 200 | 150 | 7 | 44a68bacdb3d5bf563bd35952176995850933a81 | |
| ToppCell | Tracheal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.31e-06 | 200 | 150 | 7 | c318d14bd6fd6f42c597eb55ac9e2f48008aeb9b | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 5.31e-06 | 200 | 150 | 7 | a7ef7022b8efcaedb7319b0b43d8c4e99d788fe2 | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-2m-Neuronal-Intermediate|2m / Sample Type, Dataset, Time_group, and Cell type. | 5.31e-06 | 200 | 150 | 7 | 2a635694844ddabcd98462c5636a6f41a3f08a46 | |
| ToppCell | LPS_IL1RA_TNF-Mesenchymal_fibroblastic|LPS_IL1RA_TNF / Treatment groups by lineage, cell group, cell type | 5.31e-06 | 200 | 150 | 7 | dc61016c61729f69649cfb21f6264e685ce83dea | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 5.31e-06 | 200 | 150 | 7 | fb53be20392a8309a7393774c774a1b1aec6e676 | |
| ToppCell | Control_saline-Mesenchymal_fibroblastic-Fibroblasts-MatrixFB|Control_saline / Treatment groups by lineage, cell group, cell type | 5.31e-06 | 200 | 150 | 7 | bd8cf33502adea320e91ca2af14e1911d88ad374 | |
| ToppCell | Control-Fibroblasts-Mesothelial_FB|Control / group, cell type (main and fine annotations) | 7.74e-06 | 139 | 150 | 6 | e769beb031b262dd92c9605b07dbf3c29fb82520 | |
| ToppCell | Children_(3_yrs)-Epithelial-basal_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 1.55e-05 | 157 | 150 | 6 | 6ee2692f705bdd93ba523dffaf2f0cd921b47e28 | |
| ToppCell | P15-Mesenchymal-mesenchymal_fibroblast-mesenchymal_progenitor_cell|P15 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.43e-05 | 170 | 150 | 6 | ba4ba66b624089ed50a9083176386c7941b4c7a3 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.68e-05 | 173 | 150 | 6 | 1f16d47f5548e257e4b17f8070c5619780a9c5fd | |
| ToppCell | 368C-Endothelial_cells-Endothelial-B_(Artery)-|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.68e-05 | 173 | 150 | 6 | ec88e871b49331fca59bc610a8ae58e2d5e76bc1 | |
| ToppCell | 368C-Endothelial_cells-Endothelial-B_(Artery)|368C / Donor, Lineage, Cell class and subclass (all cells) | 2.68e-05 | 173 | 150 | 6 | 22200fe74e33e2beae0eed289ca8476bbc0b1b2d | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Mesenchymal_Myocytic-myocytic_fibroblast-Myofibroblasts-Myofibroblasts_L.2.3.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.86e-05 | 175 | 150 | 6 | 1799a7be623dc3bf53ba580a7c47d2619969d708 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_G2M|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.86e-05 | 175 | 150 | 6 | 3e56695a9db97cb1d3503425c48eb79bbf99213e | |
| ToppCell | droplet-Heart-nan-3m|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.95e-05 | 176 | 150 | 6 | 749b47eac5436fa34e0d243ffbc6f1897f4e431e | |
| ToppCell | 3'-Child09-12-SmallIntestine-Mesenchymal-fibroblastic-Stromal_4_(MMP1+)|Child09-12 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.05e-05 | 177 | 150 | 6 | ac90e4ce5be304a5a7473736397327010f2d1999 | |
| ToppCell | PND28-Endothelial-Endothelial_blood-vessel-Macrovascular_EC|PND28 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.05e-05 | 177 | 150 | 6 | 6f6cf93893daac6ae228df36219ee3acf8de8f97 | |
| ToppCell | facs-Lung-18m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.05e-05 | 177 | 150 | 6 | d68132e145bd413404fdbe215b5dbe520e756e50 | |
| ToppCell | 367C-Endothelial_cells-Endothelial-B_(Artery)|367C / Donor, Lineage, Cell class and subclass (all cells) | 3.15e-05 | 178 | 150 | 6 | e1e96a0e3ff718ebf676a982bc63e8ced6984059 | |
| ToppCell | 367C-Endothelial_cells-Endothelial-B_(Artery)-|367C / Donor, Lineage, Cell class and subclass (all cells) | 3.15e-05 | 178 | 150 | 6 | 363e8b23b3834692a8a79e5fdc7b43bd3a4dab5e | |
| ToppCell | 10x_3'_v3-blood_(10x_3'_v3)-myeloid-myeloid_granulocytic-granulocyte|blood_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.25e-05 | 179 | 150 | 6 | 140dd7dbac48f5f07279f31bf971d7fbd41fa18b | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.45e-05 | 181 | 150 | 6 | 4d7793026373cbcf04b15c77f95f1025d07d4c00 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.45e-05 | 181 | 150 | 6 | 5f2d3a08577c440c944778d07aa993c6e7873f3d | |
| ToppCell | 3'-GW_trimst-2-LargeIntestine-Mesenchymal-myocytic-SMC_(PART1/CAPN3+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.45e-05 | 181 | 150 | 6 | beb2771820956be8b190c0088ae3c4efdb53c897 | |
| ToppCell | renal_cortex_nuclei-Adult_normal_reference-Epithelial-Renal_corpuscle_epithelial_cell-parietal_epithelial_cell-Parietal_Epithelial_Cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 3.45e-05 | 181 | 150 | 6 | c7c5f7d4c397b4613c772413a0a679377efffff3 | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.56e-05 | 182 | 150 | 6 | fbd5e332df73bf7141c822fa67b76367dc962017 | |
| ToppCell | E18.5-samps-Mesenchymal-Myofibroblast|E18.5-samps / Age Group, Lineage, Cell class and subclass | 3.67e-05 | 183 | 150 | 6 | de08f9ea02b7244d5a8788064631d10f06565337 | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.67e-05 | 183 | 150 | 6 | 3427f3cbe6ea81709750e7dd3ff378f03ae65eab | |
| ToppCell | 5'-Parenchyma_lung-Endothelial-Blood_vessel_EC-pulmonary_artery_endothelial_cell-EC_arterial-EC_arterial_L.2.4.1.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.67e-05 | 183 | 150 | 6 | ce8be9418b473ea94ec806edc7a2078cc30c1703 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.67e-05 | 183 | 150 | 6 | 06a68fa2be36448064f4668be24a5b85ad85c6e8 | |
| ToppCell | droplet-Lung-30m-Endothelial-arterial_endothelial-pulmonary_artery_endothelial_cell-pulmonary_artery_endothelial_cell_l27|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.67e-05 | 183 | 150 | 6 | 351d575339038bd4a66f408da518c567444208e8 | |
| ToppCell | PND10-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-AEC-AEC_prolif|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 3.90e-05 | 185 | 150 | 6 | 87151ab95530e70d61328b336518df58db584acb | |
| ToppCell | COVID-19-Fibroblasts-Adventitial_FB|COVID-19 / group, cell type (main and fine annotations) | 3.90e-05 | 185 | 150 | 6 | a5aebf2b9b05b550d021272731d68af9a6b1229d | |
| ToppCell | Children_(3_yrs)-Endothelial-endothelial_cell_of_artery-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 3.90e-05 | 185 | 150 | 6 | a7ae76058b2082020cadec49d63b9f4e24d21734 | |
| ToppCell | droplet-Lung-nan-21m-Endothelial-Artery_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.02e-05 | 186 | 150 | 6 | 5d0cd07b6b51e8ce9e1da949f757dc4575ec5752 | |
| Drug | AC1L1KMJ | COL6A3 ANK2 APC2 ACTN1 COL24A1 DST SACS PI4KB CLTC TJP2 MACF1 LMAN2 DNM1 PKN3 | 2.46e-06 | 476 | 146 | 14 | CID000030956 |
| Drug | carmustine; Down 200; 100uM; MCF7; HT_HG-U133A | 4.65e-06 | 194 | 146 | 9 | 6914_DN | |
| Disease | Intellectual Disability | EIF4A3 SYNE1 APC2 KDM3B NSUN2 FRY NF1 NRXN1 SACS MACF1 DYNC1H1 DYNC1I2 MAN1B1 | 3.25e-07 | 447 | 144 | 13 | C3714756 |
| Disease | amino acid measurement | ABCA12 SYNE1 DGKB MCCC1 DNAH7 COL24A1 TENM4 PXDN CLU PTPRN2 PTPRR VCAN NR3C2 CAMTA1 DNM1 | 1.25e-06 | 678 | 144 | 15 | EFO_0005134 |
| Disease | Drugs used in diabetes use measurement | 3.81e-05 | 255 | 144 | 8 | EFO_0009924 | |
| Disease | Moyamoya Disease | 7.36e-05 | 17 | 144 | 3 | C0026654 | |
| Disease | Degenerative polyarthritis | 9.50e-05 | 93 | 144 | 5 | C0029408 | |
| Disease | Osteoarthrosis Deformans | 9.50e-05 | 93 | 144 | 5 | C0086743 | |
| Disease | Colorectal Carcinoma | SFRP1 ANK2 ABCA12 SYNE1 APC2 PSMC5 LIG3 NF1 AKAP9 SACS PTPRN2 NR3C2 | 1.78e-04 | 702 | 144 | 12 | C0009402 |
| Disease | Brugada Syndrome (disorder) | 2.14e-04 | 24 | 144 | 3 | C1142166 | |
| Disease | cortical surface area measurement | GDF5 CNBD1 SFRP1 MECOM EXTL3 DNAH7 TINAGL1 COL24A1 ARID1B CCDC88A VCAN MDC1 MACF1 ARHGAP28 NR3C2 SUFU SOS1 | 3.13e-04 | 1345 | 144 | 17 | EFO_0010736 |
| Disease | congenital muscular dystrophy (implicated_via_orthology) | 3.50e-04 | 6 | 144 | 2 | DOID:0050557 (implicated_via_orthology) | |
| Disease | intellectual disability (implicated_via_orthology) | 5.05e-04 | 75 | 144 | 4 | DOID:1059 (implicated_via_orthology) | |
| Disease | Profound Mental Retardation | 6.15e-04 | 139 | 144 | 5 | C0020796 | |
| Disease | Mental Retardation, Psychosocial | 6.15e-04 | 139 | 144 | 5 | C0025363 | |
| Disease | Mental deficiency | 6.15e-04 | 139 | 144 | 5 | C0917816 | |
| Disease | Malignant neoplasm of breast | SFRP1 ANK2 SYNE1 APC2 MECOM ITGA9 ADHFE1 ARID1B NF1 AKAP9 KCNT2 SLC39A6 MACF1 HERC2 | 8.05e-04 | 1074 | 144 | 14 | C0006142 |
| Disease | cervical cancer | 9.85e-04 | 40 | 144 | 3 | MONDO_0002974 | |
| Disease | Short Stature, CTCAE | 1.04e-03 | 10 | 144 | 2 | C2919142 | |
| Disease | Short stature | 1.04e-03 | 10 | 144 | 2 | C0349588 | |
| Disease | Abnormality of nervous system morphology | 1.04e-03 | 10 | 144 | 2 | C4022810 | |
| Disease | calcium measurement | SLC25A37 ARID1B KCNT2 PTPRN2 MACF1 LMAN2 SERPINF2 FER1L5 PKN3 SOS1 | 1.06e-03 | 628 | 144 | 10 | EFO_0004838 |
| Disease | spontaneous preterm birth, parental genotype effect measurement | 1.26e-03 | 11 | 144 | 2 | EFO_0005939, EFO_0006917 | |
| Disease | risk-taking behaviour | HLA-DQB1 BIRC6 ARID1B TENM4 NF1 KCNT2 NRXN1 PTPRN2 KIAA1328 ARHGAP28 USP4 | 1.36e-03 | 764 | 144 | 11 | EFO_0008579 |
| Disease | testosterone measurement | ANK2 DGKB MECOM BIRC6 ADCY6 SLC25A37 ARID1B NF1 NRXN1 SUGCT MACF1 LMAN2 SERPINF2 PKN3 SOS1 | 1.46e-03 | 1275 | 144 | 15 | EFO_0004908 |
| Disease | illegal drug consumption | 1.78e-03 | 13 | 144 | 2 | EFO_0005431 | |
| Disease | cancer (implicated_via_orthology) | 2.08e-03 | 268 | 144 | 6 | DOID:162 (implicated_via_orthology) | |
| Disease | lung carcinoma, estrogen-receptor negative breast cancer, ovarian endometrioid carcinoma, colorectal cancer, prostate carcinoma, ovarian serous carcinoma, breast carcinoma, ovarian carcinoma, lung adenocarcinoma, squamous cell lung carcinoma | 2.11e-03 | 52 | 144 | 3 | EFO_0000305, EFO_0000571, EFO_0000708, EFO_0001071, EFO_0001075, EFO_0001663, EFO_1000650, EFO_1001515, EFO_1001516, MONDO_0005575 | |
| Disease | response to cisplatin, platinum measurement | 2.23e-03 | 53 | 144 | 3 | EFO_0010154, GO_0072718 | |
| Disease | X-12063 measurement | 2.24e-03 | 186 | 144 | 5 | EFO_0021283 | |
| Disease | body weights and measures, body height | 2.38e-03 | 15 | 144 | 2 | EFO_0004324, EFO_0004339 | |
| Disease | RASopathy | 2.38e-03 | 15 | 144 | 2 | cv:C5555857 | |
| Disease | hepcidin:transferrin saturation ratio | 2.38e-03 | 15 | 144 | 2 | EFO_0007902 | |
| Disease | eosinophil count | MED18 RAPGEF6 HLA-DQB1 RANBP6 ACVR1C DNAH7 MKS1 PXDN AKAP9 WDR6 HELZ2 LMAN2 CALML4 SUFU RPA2 FER1L5 | 2.54e-03 | 1488 | 144 | 16 | EFO_0004842 |
| Disease | serum albumin measurement | 2.57e-03 | 592 | 144 | 9 | EFO_0004535 | |
| Disease | Romano-Ward Syndrome | 2.71e-03 | 16 | 144 | 2 | C0035828 | |
| Disease | colorectal cancer | 2.94e-03 | 604 | 144 | 9 | MONDO_0005575 | |
| Disease | response to radiation, Urinary retention | 3.07e-03 | 17 | 144 | 2 | GO_0009314, HP_0000016 | |
| Disease | Antihistamine use measurement | 3.07e-03 | 17 | 144 | 2 | EFO_0009943 | |
| Disease | muscular dystrophy (is_implicated_in) | 3.07e-03 | 17 | 144 | 2 | DOID:9884 (is_implicated_in) | |
| Disease | hippocampal volume | 3.46e-03 | 297 | 144 | 6 | EFO_0005035 | |
| Disease | fish consumption measurement | 3.82e-03 | 64 | 144 | 3 | EFO_0010139 | |
| Disease | Headache | 3.82e-03 | 64 | 144 | 3 | HP_0002315 | |
| Disease | hematocrit | PLSCR4 CHRNA9 HLA-DQB1 FRMD7 MECOM PLEKHA6 ACVR1B SLC25A37 ARID1B SUGCT LMAN2 ZNF345 | 4.07e-03 | 1011 | 144 | 12 | EFO_0004348 |
| Disease | Microcephaly | 4.34e-03 | 67 | 144 | 3 | C0025958 | |
| Disease | synophrys measurement | 4.52e-03 | 68 | 144 | 3 | EFO_0007906 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| VMAREHAPSIIFMDE | 236 | P62195 | |
| FAEPQVLHNGLVMEM | 366 | Q9HAC7 | |
| SAIMVENTFLSIPHM | 211 | Q7L211 | |
| QVSLLAVDEMHMSLP | 316 | Q8N1M1 | |
| QLESLEQMEHPDMSL | 516 | Q96MC4 | |
| SEQGAQDSPTHLEMM | 146 | Q99996 | |
| NMMTLAEHIIEATPD | 1396 | Q9Y6Y1 | |
| VPENTMHAMQQKLED | 301 | P12814 | |
| NQPEIDQHLAMMVAL | 1906 | Q9NR09 | |
| HLMDQSVTEVPDVME | 2786 | P13611 | |
| LMANASEMDRQSHPV | 1446 | Q6UVK1 | |
| TFLTIMHMQIKQEDP | 111 | Q96GE6 | |
| HLDEQFTVPVEMMQA | 256 | P08697 | |
| LPQHVAMEMKEDINT | 346 | O43306 | |
| DTMAVTAMIQSHLPE | 1591 | Q86UK0 | |
| MAPEVLDETINMKHF | 381 | P36896 | |
| EFFQEAQTMMKLSHP | 456 | P51813 | |
| MNNLPAHDMELASRV | 496 | Q8IZP9 | |
| PEMLDDTMNVNIFES | 371 | Q8NER5 | |
| VFQLMVAEIMPASEN | 281 | Q9UGM1 | |
| TDDMMVPDQRINHES | 1566 | Q8NFD5 | |
| IHAEAPEFMEMSVEQ | 166 | P06576 | |
| EEVVEMSHMPGDLFN | 436 | O75943 | |
| EEPVQSNMDISTGHM | 716 | Q92932 | |
| FHPQMSAIENMAEKL | 856 | Q03112 | |
| TTQLIEMLHADMNVP | 191 | Q08J23 | |
| NRMDIVHLMETNTEP | 3641 | Q01484 | |
| HMPEEQAFSVLVKIM | 661 | Q9Y3P9 | |
| QSNHMDMVRIESPEE | 86 | P49914 | |
| MHFDTLLDDGVINMS | 281 | O95340 | |
| TLVNKEPDSMLAHMF | 106 | Q7L273 | |
| HAVIQTLMNSMDPES | 446 | P43026 | |
| PDLVFNEEKMHQSAM | 831 | P08235 | |
| VQSMEDEPTQAFMLT | 711 | Q14676 | |
| MKLFQLMVEHTPDEE | 271 | Q12907 | |
| EQTERNIHPTAMMFT | 1951 | O95714 | |
| HQTFMEEMTRKQPDV | 7076 | Q03001 | |
| SFMHSMDPQLERQVE | 646 | Q05193 | |
| MFAEQELPAVLMDQS | 626 | Q6ZUT3 | |
| LPHEILEMTNKFMTD | 221 | P38919 | |
| SLDMLSHPQDSMELV | 411 | Q13409 | |
| MENEIFTPLLEQFMT | 1 | Q3V6T2 | |
| NLVTLPQMHLAITMD | 151 | Q6X9E4 | |
| MEEIFHQILQTMPGI | 206 | Q9H2K0 | |
| QHFEPLEMMTCFETN | 126 | Q9NRQ2 | |
| MMEEIDRFQVPTAHS | 1 | Q8IW50 | |
| MADSMFVIPALQVAH | 411 | O00748 | |
| LIHVMLMDNSAPQSE | 246 | Q7LBC6 | |
| PEHVEIQKMMDSLFL | 491 | O00566 | |
| LNNMPVMEQSVLAHI | 461 | Q9UGL1 | |
| ITELTHPANMRFMQF | 836 | Q6UVM3 | |
| FMKIQLPVVMHTEAE | 726 | Q9ULB1 | |
| FLHDNMVEIPNRIMF | 616 | P49916 | |
| MFTISDHQPEQRGMF | 171 | O95613 | |
| MGMHRTPEELEENQI | 556 | Q86T90 | |
| AEHQTFMEEMTRKQP | 6921 | Q9UPN3 | |
| LPASHMELAQELMET | 541 | Q9UKM7 | |
| PESDVLMQDFHMVES | 51 | A2A3N6 | |
| MEPETFLDHEMVFLL | 46 | Q9BUE0 | |
| HLLQSEFMEIPMNFV | 391 | Q15256 | |
| MDVFRAMHPELDIVQ | 106 | A8MWK0 | |
| INDHSPMFTEKEMIL | 126 | Q9NRJ7 | |
| RHLITMAQIDQADMP | 456 | Q58A45 | |
| DNTLVLMVPLMHEVD | 756 | Q13797 | |
| LMASLDQPTQTVVMH | 831 | Q99613 | |
| TFQILVMLEMTPQHG | 186 | P01920 | |
| LDELPHVETQFSMQM | 166 | O95996 | |
| AVLASMDNENMHTPD | 351 | P51553 | |
| MMQNVHLAPETDEDD | 1 | Q13099 | |
| NMTHEDDVPINCTMV | 881 | Q5JSL3 | |
| TTEDCPSIMEQFHMR | 111 | P22914 | |
| VSPLVHAMSEPNFME | 316 | O43909 | |
| EPLNMHMFNLENFTS | 191 | P12111 | |
| QMNLIFEPMDLEVAS | 1726 | Q8WXX0 | |
| QVATMQMELEALHPQ | 2601 | Q8WXX0 | |
| DVTELNPILHEMMEE | 191 | Q9Y6T7 | |
| MAFPVDMLENCSHEE | 1 | Q9Y6X4 | |
| MNTRLQVEHPVTEMI | 336 | Q96RQ3 | |
| SFMSIMEQPLDLTHI | 4016 | Q14204 | |
| PMVFHMEEDQEELIF | 96 | Q4VXA5 | |
| QHQSMPGTMAEAEDL | 541 | Q9NV70 | |
| QVHEVSSMPELLNMS | 2851 | Q5TBA9 | |
| EQMVDLVTTDDMHPF | 1616 | Q9BYK8 | |
| ENHAEIMQAVRLPLM | 216 | Q96Q07 | |
| GTQMTPQHMEELAEQ | 101 | O43889 | |
| QKHFSEDNNEMIPME | 706 | Q99590 | |
| EFMIMFDPNINHISK | 1576 | Q9NZJ4 | |
| PLRMVSEEMEEQVHS | 161 | Q99661 | |
| MQNVEHVPLSLDRAM | 186 | P20618 | |
| LFDNEVLPDHMTMKQ | 221 | Q9BSM1 | |
| DLMMQIHEDVFPEPQ | 646 | Q6P5Z2 | |
| FTAQMFPERHLEMAE | 371 | Q8IWW8 | |
| EVMMQEAFEVPSTQL | 166 | Q92552 | |
| ELMEMEPTFVHASSQ | 466 | Q5HYW3 | |
| PMFHQAFEDVVVVMI | 141 | Q8WVZ7 | |
| ELMENGPVQALMEVH | 356 | Q9GZM7 | |
| LLEFMHQLPAFANMT | 271 | Q8TEU7 | |
| PESQMAEHQALMDEI | 5996 | Q8NF91 | |
| MMPNFKELIHFEVSI | 516 | A0AVI2 | |
| IEGAVMTEMPQESFH | 401 | Q5TCX8 | |
| YLMEVNLPDEMHSLT | 311 | Q53T94 | |
| EYLEELPTMMQHFSQ | 126 | Q03013 | |
| SMATLLHDAVMNPAE | 151 | Q9NYZ2 | |
| SDIAMLQLHLPMNFT | 171 | A8MTI9 | |
| YTPSMHQEAQEETVM | 21 | Q86UD5 | |
| FMDPVENQALHPVIM | 36 | A6NCI5 | |
| PHSKVIQMDVALFEM | 106 | Q8N5I9 | |
| FHMSMTEEQLQLLVE | 776 | Q9UBF8 | |
| VLMDMFHQDVEDINI | 171 | Q07889 | |
| MVLPNLLEHETMAEV | 76 | Q8N474 | |
| QFMMVEQENIDPLHV | 541 | Q9H0H5 | |
| QAVPHILAMMVDLQD | 311 | O60518 | |
| ALVDMVPEMLHNDAS | 701 | Q13433 | |
| FMAPIDHTTMNDDAR | 526 | Q9NY61 | |
| MMTPINDLHTADSLN | 111 | P35612 | |
| EMNLMHAPQVADAIL | 586 | Q00610 | |
| TLEVMPQNESETQMF | 266 | Q8NA66 | |
| PFLEMIHEAQQAMDI | 246 | P10909 | |
| LHTNELMEMQPILNT | 416 | Q17RW2 | |
| SLTDQHVQLPMAMTA | 151 | P42765 | |
| HVQLPMAMTAENLAV | 156 | P42765 | |
| LLEFMHQLPAFANMT | 126 | Q9Y4G8 | |
| LESALMGTHQELEMF | 561 | Q9Y2H5 | |
| MSAEDEPQHLEFTMQ | 101 | O94967 | |
| VMVNGTPMEDVLHSF | 86 | Q9UDY2 | |
| IFQMDEGLNHIMPRD | 546 | Q13107 | |
| IMPLEDMNEFTTHIL | 146 | P15927 | |
| VINTPLQTMHIMADL | 196 | Q9NXB0 | |
| RSPVFNAMFEHEMEE | 221 | Q6IQ16 | |
| RSPVFSAMFEHEMEE | 221 | O43791 | |
| VQFQALHLMVMALPD | 491 | Q9P2N2 | |
| SHMEEPFLQMVQASE | 16 | A6NCN8 | |
| ETVTPDEQFTHMLMQ | 806 | Q92626 | |
| ESRIQHMLLTEDPQM | 171 | Q9UMX1 | |
| SHMPEIAQEAMEALL | 536 | P21359 | |
| METIIMRHEENEIPS | 996 | Q6N022 | |
| MDDNTFAMAEHPDVQ | 346 | Q6ZSY5 | |
| ALEHDIVQDIPSMMN | 821 | Q8NDW8 | |
| MNSTVFHVPDVADMD | 1081 | Q9NNW5 | |
| NFLTMDSPMQIHFEQ | 1716 | Q14997 | |
| LDESDHITMIDFPQM | 236 | Q9BVS4 | |
| RPAHNQMDMFVTLSV | 191 | Q8IY26 | |
| HMQGQEALFSEDMPL | 136 | Q8NAM6 | |
| METQFPHVEARAASM | 221 | Q9BXU3 | |
| MAITEHPENFNLMFT | 591 | Q9ULT0 | |
| QEGHFSEMIFTPEDM | 31 | Q14585 | |
| PTQVSDMMHQDRAFA | 291 | Q5MNZ9 | |
| QIAHMVSMPGDELVQ | 146 | Q6ZQQ6 | |
| GQIPQEDMDVALMEH | 976 | Q8TD43 | |
| ELEIPEQQVDMHDML | 111 | Q6P9G9 | |
| EIDFSMEESMIHLPN | 436 | P35573 | |
| MHVMPEDDVFFIANV | 651 | O94898 |